Abstract
The intestine is quite distinct from other organs which are involved in chronic inflammatory/autoimmune diseases. Mucosal surfaces, in particular the intestinal mucosa, represent the major interface between the immune system and the antigens and microbes of the external environment. In order to deal with this challenge a specialized mucosal immune system has evolved, which is marked by certain features distinct to this system1. The massive antigenic challenge and the specialized features of the mucosal immune system add further complexity to our potential understanding of the mechanisms of inflammatory bowel disease (IBD) compared to diseases such as autoimmune diabetes or multiple sclerosis, which affect organs that are largely sequestered from antigenic challenge.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
MacDermott RP, Elson CO, editors. Mucosal Immunology, vol. 1. Philadelphia: W.B. Saunders; 1991.
Mestecky J, McGhee JR, Elson CO. Intestinal IgA system. Immunol Allergy Clin N Am. 1988; 8: 349–68.
Brandtzaeg P. Overview of the mucosal immune system. In: Mestecky J, McGhee JR, editors. New strategies for oral immunization. New York: Springer-Verlag; 1989: 13–25.
Xu-Amano J, Jackson RJ, Staats HF et al. Helper T cell subsets for IgA responses. Oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa-associated tissues. J Exp Med. 1993; 178: 1309–20.
Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989; 7: 145–73.
Heinzel FP, Sadick MD, Holoday BJ, Coffman RL, Locksley RM. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leischmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med. 1989; 169: 59–72.
Beagley KW, Fujihashi K, Lagoo AS, Elson CO. Regional differences in mucosal lymphoid cells of murine small vs. large bowel. Gastroenterology. 1992; 102: A593.
Miller A, Lider O, Roberts AB, Sporn MB, Weiner HL. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci USA. 1992; 89: 421–5.
Dielemann LA, Elson CO, Tennyson GS, Beagley KW. Cytokine expression during acute colonic injury in mice. Gastroenterology. 1992; 102: A616.
Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell. 1993; 75: 253–61.
Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993; 75: 263–74.
Mombaerts P, Mizoguchi E, Grusby MJ, Glimcher LH, Bhan AK, Tonegawa S. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell. 1993; 75: 1–20.
Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapteninduced model of chronic inflammation and ulceration in the rat colon. Gastroenterology. 1989; 96: 795–803.
Miller SD, Butler LD, Cleveland RP, Moorhead JW, Claman HN, Chiller JC. T-cell responses induced by the parenteral injection of antigen-modified syngeneic cells. II. Mechanisms, specificity, and cellular analysis of 2,4,6-trinitrophenol (TNP)-specific cytolytic response priming by intravenous versus subcutaneous injection with TNP-modified syngeneic cells. Cell Immunol. 1983; 82: 378–93.
Beagley KW, Tennyson GS, Black CA, Sharmanov A, Cummings OW, Elson CO. Hapteninduced colitis in mice. Differences in susceptibility among mouse strains. 1994 ( Submitted).
Sharmanov AT, Elson CO, Kiyono H et al. Murine hapten-induced colitis: antibody response analysis and protection after oral tolerance induction. 1994 (Submitted).
Asherson GL, Zembala M, Perera MACC, Mayhew B, Thomas WR. Production of immunity and unresponsiveness in the mouse by feeding contact sensitizing agents and the role of suppressor cells in the Peyer’s patches, mesenteric lymph nodes and other lymphoid tissues. Cell Immunol. 1977; 33: 145–55.
Powrie F, Leach MW, Mauze S, Caddie LB, Coffman RL. Phenotypically distinct subsets of CD4 T cells induce or protect from chronic intestinal inflammation in C.B-17 scid mice. Eur J Immunol. 1993; 5: 1461–71.
Morrissey PJ, Charrier K, Braddy S, Liggitt D, Watson JD. CD4 T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4 + T cells. J Exp Med. 1993; 178: 237–44.
Bucy RP, Xu XY, Li J, Huang GQ. Cyclosporin A-induced autoimmune disease in mice. J Immunol. 1993; 151: 1039–50.
Taurog JD, Richardson JA, Hadavand R et al. The germfree state protects HLA-B27 transgenic rats from gut and joint inflammation. FASEB J. 1994;8 (In press).
Sundberg JP, Elson CO, Bedigian H, Birkenmeier EH. Spontaneous, heritable colitis in a new substrain of C3H/HeJ mice. Gastroenterology. 1994 (in press).
Brandwein SL, McCabe RP, Dadrat A et al. Immunologic reactivity of colitic C3H/BejBir mice to enteric bacteria. Gastroenterology. 1994; 106: A656.
Cohen IR. The cognitive paradigm and the immunological homunculus. Immunol Today. 1992; 13: 490–4.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Kluwer Academic Publishers and Axcan Pharma, Inc.
About this chapter
Cite this chapter
Elson, C.O. et al. (1994). Regulation of mucosal immune responses — the missing link in IBD?. In: Sutherland, L.R., et al. Inflammatory Bowel Disease. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0371-5_8
Download citation
DOI: https://doi.org/10.1007/978-94-009-0371-5_8
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6653-2
Online ISBN: 978-94-009-0371-5
eBook Packages: Springer Book Archive